Project Grant R35GM162013
- Federal Grant Award Summary The University of Southern California received a $2.28 million Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded September 1, 2025, with completion targeted for August 31, 2029. The award funds fundamental biomedical research investigating protein aggregation mechanisms controlled by disaggregases—biological molecules including macromolecular chaperones,...
- Federal Grant Award Summary The University of Southern California received a $589,500 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective May 1, 2026 through January 31, 2031. Dr. Li's laboratory will conduct computational research to interrogate epigenetic regulation in cellular plasticity and heterogeneity, addressing critical gaps in understanding how epigenetic modifications and...
- Federal Grant Award Summary The University of Southern California received a $351,920 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2030. This five-year award supports fundamental basic research investigating the cellular and molecular determinants of regenerative capabilities in amniotes, with particular focus on understanding...
- Federal Grant Award Summary The University of Southern California received a $395,200 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025 through August 31, 2030. This five-year research initiative focuses on developing novel computational methods to analyze population genomics data across global human populations, with particular emphasis on inferring complex...
- Federal Grant Award Summary The University of Southern California received a $451,259 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through June 30, 2029. This award supports fundamental research investigating heterochromatin repair mechanisms from a chromatin perspective. The project will deliver scientific research outputs focused on understanding how...
- Federal Grant Award Summary The University of Southern California received a $456,500 Project Grant award from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through July 31, 2030. The grant supports fundamental research into the structural and biosynthetic mechanisms of modular polyketide synthases (PKS), which are enzymatic assembly lines used by microorganisms to produce complex small...
- Federal Project Grant Award Summary The University of Southern California received a $413,300 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded August 15, 2025, with completion targeted for July 31, 2030. The grant funds research investigating three critical areas of human genetics: the role of natural selection in shaping genetic architecture of complex traits, gene-environment...
- Federal Project Grant Award Summary The University of California, San Diego received a $327,019 Project Grant award dated July 25, 2025, from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The award supports research through April 30, 2030, focusing on developing innovative biophysical and computational frameworks to understand how cells transform during embryogenesis and stem cell differentiation. The...
- Federal Grant Award Summary The University of Southern California received a $456,500 Project Grant from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859), awarded February 15, 2026, with completion targeted for December 31, 2030. This five-year research initiative investigates the mechanism and function of XIST, a long non-coding RNA (lncRNA), in maintaining X chromosome inactivation (XCI)—the epigenetic silencing...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded Columbia University's Health Sciences Division a $443,878 Project Grant on August 5, 2025, under the Biomedical Research and Research Training program (CFDA 93.859) to support research on geometrical regulation of collective cellular responses in three-dimensional space and time. The research investigates how macroscopic tissue geometries—including curvature, concavity, continuity, and aspect...
The University of Southern California received a $656,500 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective April 1, 2026 through January 31, 2031. The award supports research to develop and apply innovative technologies for controlling cell differentiation and patterning in multicellular development, using a multilayered arterial wall as a case study. The research addresses fundamental questions about how mammalian cells integrate various biological inputs to generate complex spatial arrangements of differentiated cell types in tissues and organs. The project encompasses two primary research tracks. The first involves developing new technologies for three-dimensional (3D) differentiation control, including methods to create defined-thickness cellular layers around spherical or thread-like scaffolds to model organs with radial symmetry (such as blood vessels, liver, and skin) and autonomous patterning genetic circuits to generate two-dimensional (2D) and 3D gene expression patterns. The second track focuses on studying and controlling cell-to-cell communication between differentiating endothelial and vascular support cells using patterned synthetic signaling systems. These deliverables build upon synthetic genetic networks previously developed by the laboratory to reconstruct complex multicellular arrangements and advance understanding of developmental biology applicable to addressing congenital disorders and adult diseases.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $656.5k | 3/30/26 |